Results 261 to 270 of about 107,086 (298)

Costimulatory connections: CARMIL2 and CD28

Journal of Experimental Medicine
In this issue of JEM, Zhang et al. (https://doi.org/10.1084/jem.20250339) report that a gain-of-function mutation in CARMIL2, previously identified in patients, is sufficient to replace the contribution of CD28 to NF-κB activation and downstream effects in T cells, including in the setting of an anti-tumor response.
openaire   +2 more sources

Mechanisms of CD28 signalling

Research in Immunology, 1995
H, Schneider, Y C, Cai, D, Cefai, M, Raab, C E, Rudd   +4 more
openaire   +2 more sources

CD28

AfCS-Nature Molecule Pages, 2005
openaire   +1 more source

Cattle CTLA-4, CD28 and chicken CD28 bind CD86: MYPPPY is not conserved in cattle CD28

Immunogenetics, 1996
K R, Parsons, J R, Young, B A, Collins, C J, Howard   +3 more
openaire   +2 more sources

Signalling intermediates of CD28

Research in Immunology, 1995
Y, Ben-Neriah, I, Alkalay, A, Yaron, A, Hatzubai, S, Jung   +4 more
openaire   +2 more sources

CD28

1997
A. Neil Barclay, Marion H. Brown, S.K. Alex Law, Andrew J. McKnight, Michael G. Tomlinson, P. Anton van der Merwe   +5 more
openaire   +1 more source

PD-1 blockade-unresponsive human tumor-infiltrating CD8+ T cells are marked by loss of CD28 expression and rescued by IL-15

Cellular and Molecular Immunology, 2020
Seongju Jeong, Su-Hyung Park, Chang Gon Kim   +2 more
exaly  

CD28

2009
openaire   +1 more source

Association of Graves’ Disease and Prevalence of Circulating IFN-γ-producing CD28− T Cells

Journal of Clinical Immunology, 2008
Xiang Lu, Jin Jing, Yibei Zhu
exaly  

Role of CD28 in Acute Graft-Versus-Host Disease

Blood, 1998
Paul J Martin, Xue-Zhong Yu
exaly